Parnax Lab Limited (BOM:506128)
118.20
-11.15 (-8.62%)
At close: Aug 17, 2026
Parnax Lab Market Cap
Parnax Lab has a market cap or net worth of 1.36 billion as of August 17, 2026. Its market cap has decreased by -5.97% in one year.
Market Cap
1.36B
Enterprise Value
2.16B
Revenue
2.52B
Ranking
n/a
PE Ratio
15.19
Stock Price
118.20
ChartMarket Cap Chart
Since September 15, 2009, Parnax Lab's market cap has increased from 3.36M to 1.36B, an increase of 40,304.76%. That is a compound annual growth rate of 42.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 1.36B | -9.08% |
| Dec 31, 2025 | 1.49B | -22.62% |
| Dec 31, 2024 | 1.93B | 90.56% |
| Dec 29, 2023 | 1.01B | 21.10% |
| Dec 30, 2022 | 836.15M | 86.38% |
| Dec 31, 2021 | 448.63M | 86.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Accretion Pharmaceuticals | 2.12B |
| Coral Laboratories | 2.05B |
| Kerala Ayurveda | 2.04B |
| Sat Kartar Life | 1.91B |
| Bilcare | 1.90B |
| Bio Medica Laboratories | 1.82B |
| Speciality Medicines | 1.43B |
| Bal Pharma | 1.38B |